Anti-tachycardia therapy can improve altered cardiac adrenergic function in tachycardia-induced cardiomyopathy

Annals of Nuclear Medicine

Volumn 16, Issue 7, 2002, Pages 447-453

  Ohkusu, Yasuo ^a   Takahashi, Nobukazu ^a   Ishikawa, Toshiyuki ^a   Oka, Takashi ^a   Sumita, Shinichi ^a   Kobayashi, Tsukasa ^a   Matsushita, Kohei ^a   Yamakawa, Youhei ^a   Uchino, Kazuaki ^a   Kimura, Kazuo ^a   Inoue, Tomio ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Adrenergic function; Congestive heart failure; Dilated cardiomyopathy; Iodine 123 metaiodobenzylguanidine (123I MIBG); Tachycardia induced cardiomyopathy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MEXILETINE; NITRATE; PILSICAINIDE; PROCAINAMIDE; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVERSION; CATHETER ABLATION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; PRIORITY JOURNAL; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLE; TACHYCARDIA;

EID: 12244311892     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02988640     Document Type: Article

References (33)

1. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman E, et al. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction. J Am Coll Cardiol 1986; 57: 563-570.
2. Cruz FES, Cheriex EC, Smeets JLRM, Atie J, Perres AK, Penn OCKM, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol 1990; 16: 739-744.
3. Gillette PC, Wampler DG, Garson A Jr, Zinner A, Ott D, Cooley D. Treatment of atrial automatic tachycardia by ablation procedures. J Am Coll Cardiol 1985; 6: 405-409.
4. Lemery R, Brugada P, Cherix E, Wellens HJJ. Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol 1987; 60: 1406-1408.
5. Rabbani LE, Wang PJ, Couper GL, Friedman PL. Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia. Am Heart J 1991; 121: 816-819.
6. Heinz G, Siostrzonek P, Kreiner G, Gossinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 1992; 69: 489-492.
7. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1992; 69: 1570-1573.
8. Kieny JR, Sacrez A, Facello A, Arbogast R, Bareiss P, Roul G, et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J 1992; 13: 1290-1295.
9. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: Mechanisms and clinical implications. Pacing Clin Electrophysiol 1996; 19: 95-106.
10. Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A, et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: Cardiac effects. Circulation 1987; 75: 857-867.
11. Damiano RJ, Tripp HF, Asano T, Small KW, Jones RH, Lowe JE. Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia. J Thorac Cardiovasc Surg 1987; 94: 135-143.
12. Wolff MR, De Tombe PP, Harasawa Y, Burkhoff D, Bier S, Hunter WC, et al. Alteration in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure. Circulation Res 1992; 70: 516-529.
13. Burchell SA, Spinale FG, Crawford FA, Tanaka R, Zile MR. Effect of chronic tachycardia-induced cardiomyopathy on the β-adrenergic receptor system. J Thorac Cradiovasc Surg 1992; 104: 1006-1012.
14. Schofer J, Spielman R, Schuchert A, Weber K, Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12: 1253-1258.
15. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-477.
16. 123I-MIBG. J Nucl Med 1999; 40: 6-11.
17. Sahn DJ, DeMaria A, Kissolo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
18. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7-11.
19. Gallagher JJ. Tachycardia and cardiomyopathy: The chickenegg dilemma revisited. J Am Coll Cardiol 1985; 6: 1172-1173.
20. Coleman HN, Taylor RR, Pool PE, Whipple GH, Covell JW, Ross J Jr, et al. Congestive heart failure following chronic tachycardia. Am Heart J 1971; 81: 790-798.
21. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the β-adrenergic receptor pathway in the intact failing human heart: Progressive receptor downregulation and subsensitivity to agonist response. Circulation 1986; 74: 1290-1302.
22. Spinale FG, Tanaka R, Crawford FA, Zile MR. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 1992; 85: 717-729.
23. Ohno M, Cheng CP, Litter WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 1994; 89: 2241-2250.
24. Moe GW, Stopps TP, Angus C, Forster C, De Bold AJ, Armstrong PW. Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol 1989; 13: 173-179.
25. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: A review of animal model and clinical studies. J Am Coll Cardiol 1997; 29: 709-715.
26. Armstrong PW, Stopps TP, Ford SE, De Bold AJ. Rapid ventricular pacing in the dog: Pathophysiologic studies of heart failure. Circulation 1986; 74: 1075-1084.
27. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homcy CJ, et al. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 1993; 91: 907-914.
28. Braunward E, ed. Heart Disease: A Textbook of Cardiovascular Medicine, 5th Ed, Pennsylvania; W.B. Saunders Company, 1997: 1407-1412.
29. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart hailure: Evidence for increase neuronal norepinephrine release and preserved neuronal uptake. Circulation 1993; 88: 136-145.
30. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkami P, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192-1199.
31. Yamakado K, Takeda K, Kitano T, Nakagawa T, Futagami Y, Konishi T, et al. Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy. Eur J Nucl Med 1992; 19: 265-270.
32. 123I]metaiodobenzylguanidine scinfigraphy. Circulation 1994; 89: 2843-2851.
33. Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - Implications for clinical studies. J Nucl Med 1992; 33: 1444-1450.